Synthetic lipopeptides incorporated in liposomes: In vitro stimulation of the proliferation of murine splenocytes and in vivo induction of an immune response against a peptide antigen

Molecular Immunology

Volumn 34, Issue 8-9, 1997, Pages 569-576

  Fernandes, Isabelle ^a   Frisch, Benoît ^a   Muller, Sylviane ^b   Schuber, Francis ^a  

^a CNRS   (France)

^b INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

adjuvants; Lipopeptides; Liposomes; Monophosphoryl lipid A; Peptides; Splenocytes

Indexed keywords

LIPOPEPTIDE; LIPOSOME;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL PROLIFERATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODY FORMATION; CELL DIVISION; DIPEPTIDES; ENDOCYTOSIS; FEMALE; LIPID A; LIPOPROTEINS; LIPOSOMES; MICE; MICE, INBRED BALB C; MITOSIS; PEPTIDE FRAGMENTS; SPLEEN;

ANIMALIA; MURINAE;

EID: 0030776068     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00090-4     Document Type: Article

References (42)

1. Alving C. R. (1991) Liposomes as carriers of antigens and adjuvants. Journal of Immunological Methods 140, 1-13.
2. Alving C. R. (1993) Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187, 430-46.
3. Alving C. R., Koulchin V., Glenn G. M. and Rao M. (1995) Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunological Reviews 145, 5-31.
4. Alving C. R., Richards R. L., Moss J., Alving L. I., Clements J. D., Schiba T., Kotani S., Wirtz R. A. and Hockmeer W. T. (1986) Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen. Vaccine 4, 166-172.
5. Bessler W. G., Cox M., Lex A., Suhr B., Wiesmüller K. H. and Jung G. (1985) Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. Journal of Immunology 135, 1900-1905.
6. Bessler W. G. and Jung G. (1992) Synthetic lipopeptides as novel adjuvants. Research in Immunology 143, 548-553.
7. Boeckler C., Frisch B., Muller S. and Schuber F. (1996) Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes. Journal of Immunological Methods 191, 1-10.
8. Böhlen P., Stein S., Dairman W. and Udenfriend S. (1973) Fluorometric assay of proteins in the nanogram range. Archives of Biochemistry and Biophysics 155, 213-220.
9. Buiting A. M., van Rooijen N. and Claassen E. (1992) Liposomes as antigen carriers and adjuvants in vivo. Research in Immunology 143, 541-548.
10. Friede M. (1994) Liposomes as carriers of antigens. In Liposomes as Tools in Basic Research and Industry (Edited by Philippot J. R. and Schuber F.), pp. 189-199. CRC Press, Boca Raton.
11. Friede M., Muller S., Briand J. P., Plaué S., Fernandes I., Frisch B., Schuber F., Van Regenmortel M. H. V. (1994) Selective induction of protection against influenza virus infection in mice by a lipid-peptide conjugate delivered in liposomes. Vaccine 12, 791-797.
12. Friede M., Muller S., Briand J. P., Van Regenmortel M. H. V. and Schuber F. (1993) Induction of immune response against a short synthetic peptide antigen coupled to small neutral liposomes containing monophosphoryl lipid A. Molecular Immunology 30, 539-547.
13. Fries L. F., Gordon D. M., Richards R. L., Egan J. E., Hollingdale M. R., Gross M., Silverman C. and Alving C. R. (1992) Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proceedings of the National Academy of Sciences U.S.A. 89, 358-362.
14. Frisch B., Muller S., Briand J. P., Van Regenmortel M. H. V. and Schuber F. (1991) Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen. European Journal of Immunology 21, 185-193.
15. Gregoriadis G.,Gursel I.,Gursel M. and McCormack B. (1996) Liposomes as immunological adjuvants and vaccine carriers. Journal of Controlled Release 41, 49-56.
16. Haensler J. and Schuber F. (1988) Preparation of neogalactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochimica et Biophysica Acta 946, 95-105
17. Hauschildt S., Bassenge E., Bessler W. G., Busse R. and Mulsch A. (1990a) L-Arginine-dependent nitric oxide formation and nitrite release in bone marrow-derived macrophages stimulated with bacterial lipopeptide and lipopolysaccharide. Immunology 70, 332-337.
18. Hauschildt S., Hoffmann P., Beuscher H. U., Dufhues G., Heinrich P., Wiesmüller K. H., Jung G. and Bessler W. G. (1990b) Activation of bone marrow-derived mouse production, macrophages by bacterial lipopeptide, cytokine phagocytosis and Ia expression. European Journal of Immunology 20, 63-68.
19. Heath T. D., Lopez N. G. and Papahadjopoulos D. (1985) The effects of liposome size and surface charge on liposomemediated delivery of methotrexate-gamma-aspartate to cells in vitro. Biochimica et Biophysica Acta 820, 74-84.
20. Hoffmann P., Heinle S., Schade U. F., Loppnow H., Ulmer A. J., Flad H. D., Jung G. and Bessler W. G. (1988) Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues. Immunobiology 177, 158-170.
21. Kanda P., Fritz D. A., Gage D. A. and Shuler K. R. (1995) Dependence of the murine antibody response to an anti-CD4 CDR2 VH peptide on immunogen formulation. Molecular Immunology 32, 1319-1328.
22. Machy P. and Leserman L. D. (1983) Small liposomes are better than large liposomes for specific drug delivery in vitro. Biochimica et Biophysica Acta 730, 313-320.
23. Martin F. J. and Papahadjopoulos D. (1982) Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. Journal of Biological Chemistry 2, 286-288.
24. Matthay K. K., Heath T. D. and Papahadjopoulos D. (1984) Specific enhancement of drug delivery to AKR lymphoma by antibody-targeted small unilamellar vesicles. Cancer Research 44, 1880-1886.
25. Metzger J. W., Sawyer W. H., Wile B., Biesert L., Bessler W. G. and Jung G. (1993) Interaction of immunologically-active lipopeptides with membranes. Biochimica et Biophysica Acta 1149,29-39.
26. Metzger J. W., Wiesmüller K. H. and Jung G. (1991) Synthesis of N-alpha-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. International Journal of Peptide Protein Research 38, 545-554.
27. Mishell B. B. (1980) In Selected Methods in Cellular Immunology (Edited by Mishell B. B. and Shiigi S. M.), pp. 4-6. Freeman, San Franscisco.
28. Prass W., Ringsdorf H., Bessler W. G., Wiesmüller K. H. and Jung G. (1987) Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. Biochimica et Biophysica Acta 900, 116-128.
29. Reitermann A., Metzger J., Wiesmüller K. H., Jung G. and Bessler W. G. (1989) Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten. Biological Chemistry Hoppe-Seyler 370, 343-352.
30. Richards R. L., Swartz G. M., Schultz C., Hayre M. D., Ward G. S., Ballou W. R., Chulay J. D., Hockmeyer W. T., Berman S. L. and Alving C. R. (1989) Immunogenicity of liposomal malaria sporozoite antigen in monkeys. adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A. Vaccine 7, 506-512.
31. Riddles P. W., Blakeley R. L. and Zerner B. (1979) Ellman's reagent: 5,5′-dithiobis(2nitrobenzoic acid) a reexamination. Analytical Biochemistry 94, 75-81.
32. Rouser G., Fleischer J. and Yamamoto A. (1970) Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5, 494-496.
33. Salord J. and Schuber F. (1988) In vitro drug delivery mediated by ecto-NAD + glycohydrolase ligand-targeted liposomes. Biochimica et Biophysica Acta 971, 197-206.
34. Sidwell R. W., Smee D. F., Huffman J. H., Bailey K. W., Warren R. P., Burger R. A. and Penney C. L. (1995) Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. Antiviral Research 26, 145-159.
35. Szoka F. C. and Papahadjopoulos D. (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences U.S.A. 75, 4194-4198.
36. Tsujimoto M., Kotani S., Kinoshita F., Kanoh S., Shiba T. and Kusumoto S. (1986) Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity. Infection and Immunity 53, 511-516.
37. Tsujimoto M., Kotani S., Kinoshita F., Kanoh S., Shiba T. and Kusumoto S. (1986) Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds. Infection and Immunity 53, 517-521.
38. Ullrich S. E. and Fidler I. J. (1992) Liposomes containing muramyl tripeptide phosphatidylethanolamine (MTP-PE) are excellent adjuvants for induction of an immune response to protein and tumor antigens. Journal of Leukocyte Biology 52, 489-494.
39. Verma J. N., Rao M., Amselem S., Krzych U., Alving C. R., Green S. J. and Wasser N. (1992) Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. Infection and Immunity 60, 2438-2444.
40. Wiesmüller K. H., Jung G., Gillensen D., Loffl C., Bessler W. G. and Boltz T. (1991) The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology 12, 109113.
41. Wiesmüller K. H. and Jung G., Hess G. (1983) Synthesis of the mitogenic S-[2,3bis(palmitoyloxy)propyl]-N-palrnitoylpentapeptide from Eseherichia coli lipoprotein. Hoppe-Seyler's Zeitschrift für Physiologische Chemistry 364, 593-606.
42. Woodle M. C. and Papahadjopoulos D. (1989) Liposome preparation and size characterization. Methods in Enzymology 171, 193-217.